NEW YORK (360Dx) – Ortho Clinical Diagnostics has applied for US Food and Drug Administration clearance of an integrated system for mid- and high-volume labs that it anticipates launching in the US early next year.
The high-throughput system combines automated clinical chemistry and immunoassay testing for a broad range of assays with thin film, dry slide technology that speeds throughput for selected assays.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
